Dan Mangan is a reporter covering health care and other issues for CNBC.com.
Mangan has been a journalist for more than 20 years, most recently as a general assignment/rewrite reporter at the New York Post. In his more than dozen years at The Post, Mangan routinely covered major stories, including the 9/11 terror attacks, the Bernard Madoff Ponzi scheme, the 2008 financial meltdown and a slew of juicy Gotham scandals du jour, among them the personal tribulations of Yankee slugger Alex Rodriguez.
Prior to that, Mangan began his career in his native Connecticut, writing obituaries for The Hour of Norwalk, before moving on to cover business, government and the court systems at The Hour, the Fairfield County Business Journal and The Advocate of Stamford.
Mylan CEO Heather Bresch is set to testify Wednesday before a House committee over sky-high price hikes for lifesaving EpiPens.
Less than 10 percent of authorized doctors prescribe the medication buprenorphine to more than 75 patients.
Despite rising Obamacare prices, the total premiums paid in many cases are less than work-based coverage.
A New Jersey couple said they were charged 7 percent sales tax on Charmin toilet tissue purchases despite that item being exempt from tax.
Workers are being forced to pay more out of pocket for health care than in the past.
People in consumer-directed health plans tend to pay much more out of pocket for health care than others despite lower use.
Republicans want to repeal Obamacare, but millions of people could lose coverage if that happens.
The president dropped by a meeting with insurers Monday, and wrote all insurance companies selling Obamacare plans.
GAO investigators repeatedly managed to enroll fictitious applications in health coverage.
Mylan expects the generic version of EpiPens, to eventually account for 85% of sales of its auto-injection, anti-allergy devices.